This policy brief examined how health insurance available through Covered California could cost more than some people living with HIV/AIDS can afford, undermining an important HIV prevention strategy: adherence to medication and engagement in care. People living with HIV/AIDS (PLWHA) who adhere to their drug regimens can reduce their viral load to undetectable levels, making them less likely to transmit HIV, and creating a public health imperative to reduce barriers to
care and treatment for PLWHA.
This policy brief examined how health insurance available through Covered California could cost more than some people living with HIV/AIDS can afford, undermining an important HIV prevention strategy: adherence to medication and engagement in care. People living with HIV/AIDS (PLWHA) who adhere to their drug regimens can reduce their viral load to undetectable levels, making them less likely to transmit HIV, and creating a public health imperative to reduce barriers to care and treatment for PLWHA.
Register for this one-day symposium is designed to provide participants with relevant, reliable, up-to-date information on the clinical management of HIV-infected patients who have failed one or more antiretroviral regimens, or who have demonstrated some degree of resistance to one or more antiretroviral drugs or classes of drugs.
This one-day symposium is designed to provide participants with relevant, reliable, up-to-date information on the clinical management of HIV-infected patients who have failed one or more antiretroviral regimens, or who have demonstrated some degree of resistance to one or more antiretroviral drugs or classes of drugs.
This policy brief discusses how ADAP only covers a limited range of drugs – some 184 name brand and generic drugs necessary to successfully treat HIV/AIDS and related conditions. ADAP’s low-income beneficiaries must pay for drugs not on the ADAP formulary, and for other health care costs associated with HIV disease. Under the governor’s cost-sharing proposals, these clients would face significant increases in the amount of out-of pocket costs they will be expected to meet just to access medications they must have to maintain their health.
Oral presentation by Mark Tomlinson in Aug 2012 that describes low cost platforms as essential, to be incorporated in health care budgets. The presentation emphasizes the supporting supervision and management central to the efforts of Community Health Workers that are dispersed and stretched.
This policy brief discusses the cost benefits for California to expand HIV surveillance efforts to add persons already in care to the HIV names based registry. It is estimated that each additional case registered would add $1675-$1707 to Ryan White allocations, but cost of only $992 to register. An additional $4.7 million would flow to the state as a result of adding 2800 cases to the registry.
This policy briefs addresses how will new cost-sharing fees proposed for the AIDS Drug Assistance Program affect people living with HIV and AIDS (PLWHA) in California. The governor’s cost-sharing proposal for ADAP will likely be a significant financial barrier to ADAP’s low-income beneficiaries. This is particularly problematic considering the high costs of these life-saving medications.
The governor’s cost-sharing proposal for ADAP will likely be a significant financial barrier to ADAP’s low-income beneficiaries. This is particularly problematic considering the high costs of these life-saving medications. Most ADAP beneficiaries could not afford their medications if they were financially unable to access the ADAP program.